After identifying that MYC, TP53, E2F1, and EIF4E are shown to be overexpressed in colon and rectum patient tumor samples in the GEPIA database, we then used the GEPIA database to determine which of the remaining proteins have an expressional correlation with PRMT5 and KRAS in CRC patient tumor samples. This evidence concerns the gene KRAS and colorectal carcinoma.